EBS Investing Cash Flow

Emergent Biosolutions Inc · Investing Cash Flow

EBS logo

EBS Investing Cash Flow

Latest reported-$62.00M
EBS Cash from Investing (-$225.00M → -$62.00M)
High-resolution chart · PNG

EBS investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
69,400,000
125,200,000
212,300,000
-381,300,000
-225,000,000
-151,900,000
-96,900,000
-897,200,000
-249,932,000
-76,257,000
-45,462,000
-210,052,000
-67,894,000
-40,114,000
-53,963,000
-23,456,000
-33,287,000
-30,813,000
-43,969,000
-41,638,000
-5,841,000
-18,175,000
-225,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.